Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNF alpha, and caspase 3 levels in an experimental diabetes model
dc.contributor.author | Çelik, Fatih | |
dc.contributor.author | Ulaş, Fatih | |
dc.contributor.author | Özünal, Zeynep Güneş | |
dc.contributor.author | Fırat, Tülin | |
dc.contributor.author | Çelebi, Serdal | |
dc.contributor.author | Doğan, Ümit | |
dc.date.accessioned | 2021-06-23T19:36:21Z | |
dc.date.available | 2021-06-23T19:36:21Z | |
dc.date.issued | 2014 | |
dc.department | BAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | AIM: To evaluate the influence of an intravitreal injection of bevacizumab and fasudil on the retinal vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNF alpha), and caspase 3 levels in a diabetic rabbit model. METHODS: The study included 6 healthy rabbits (Group 1), 6 rabbits with experimentally induced diabetes mellitus (DM) (Group 2), 7 rabbits with experimentally induced DM to which intravitreal bevacizumab was administered (Group 3), and 7 rabbits with experimentally induced DM to which intravitreal fasudil was administered (Group 4). An intravitreal injection of 1.25mg/50 mu L bevacizumab in the right eye of rabbits in Group 3 and an intravitreal injection of 0.0064mg/50 mu L fasudil in the right eye of rabbits in Group 4 were administered on day 21 after the induction of DM. The studied eyes of the rabbits were enucleated three days after the intravitreal injection. The TNF alpha, VEGF, and caspase 3 levels were determined using the ELISA method. RESULTS: There was a statistically significant difference in the VEGF and caspase 3 levels between groups (P=0.005 and P=0.013, respectively), but the TNF alpha level did not differ significantly between groups (P=0.792). It was found that VEGF levels were significantly lower in Group 1 and Group 3 than in Group 2 using the Mann-Whitney Utest with the Bonferroni correction (P=0.004 for both comparison). There was no statistically significant difference between other groups with regard to VEGF levels (the P value ranged between 0.015 and 0.886). Although the P values of the caspase 3 levels were 0.015 for Group 1 and Group 4, 0.038 for Group 2 and Group 3, and 0.018 for Group 3 and Group 4, these P values remained above the threshold Pvalue of 0.0083, which was the statistically significant level for post hoc tests. CONCLUSION: An intravitreal injection of bevacizumab decreased both the VEGF level, which plays a role in angiogenesis, and the caspase 3 level, which plays a role in apoptosis. Although not as effective as bevacizumab, fasudil had a beneficial effect on the VEGF levels but significantly increased the caspase 3 levels. | en_US |
dc.identifier.doi | 10.3980/j.issn.2222-3959.2014.01.10 | |
dc.identifier.endpage | 61 | en_US |
dc.identifier.issn | 2222-3959 | |
dc.identifier.issn | 2227-4898 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 24634864 | en_US |
dc.identifier.scopus | 2-s2.0-84896469793 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 57 | en_US |
dc.identifier.uri | https://doi.org/10.3980/j.issn.2222-3959.2014.01.10 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/7976 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.wos | WOS:000331497800010 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Çelik, Fatih | |
dc.institutionauthor | Ulaş, Fatih | |
dc.institutionauthor | Özünal, Zeynep Güneş | |
dc.institutionauthor | Fırat, Tülin | |
dc.institutionauthor | Çelebi, Serdal | |
dc.institutionauthor | Doğan, Ümit | |
dc.language.iso | en | en_US |
dc.publisher | Ijo Press | en_US |
dc.relation.ispartof | International Journal Of Ophthalmology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | bevacizumab | en_US |
dc.subject | caspase 3 | en_US |
dc.subject | experimental diabetes | en_US |
dc.subject | fasudil | en_US |
dc.subject | tumor necrosis factor alpha | en_US |
dc.subject | vascular endothelial growth factor | en_US |
dc.title | Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNF alpha, and caspase 3 levels in an experimental diabetes model | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- fatih-celik.pdf
- Boyut:
- 510.91 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam metin/Full text